J. Goldman & CO LP Collegium Pharmaceutical, Inc Transaction History

J. Goldman & CO LP

$3.75 Billion
Q2 2025

A detailed history of J. Goldman & CO LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, J. Goldman & CO LP holds 243,448 shares of COLL stock, worth $9.22 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

243,448

Holding current value

$9.22 Million

% of portfolio

0.19%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$24.67 - $30.44 $6.01 Million - $7.41 Million	243,448 New	243,448 $7.2 Million
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $1.71 Million - $2.45 Million	-96,347 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $430,234 - $500,291	19,790 Added 25.85%	96,347 $2.28 Million
Q1 2021 May 17, 2021	SELL	$19.25 - $26.1 $1.33 Million - $1.81 Million	-69,208 Reduced 47.48%	76,557 $1.81 Million
Q4 2020 Feb 16, 2021	BUY	$17.83 - $22.29 $1.36 Million - $1.7 Million	76,401 Added 110.15%	145,765 $2.92 Million
Q3 2020 Nov 16, 2020	SELL	$15.78 - $20.82 $2.34 Million - $3.09 Million	-148,590 Reduced 68.17%	69,364 $1.44 Million
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $2.43 Million - $3.68 Million	-156,588 Reduced 41.81%	217,954 $3.81 Million
Q1 2020 May 15, 2020	BUY	$13.89 - $25.45 $3.61 Million - $6.61 Million	259,640 Added 225.97%	374,542 $6.12 Million
Q4 2019 Feb 14, 2020	SELL	$10.7 - $22.24 $217,177 - $451,405	-20,297 Reduced 15.01%	114,902 $2.37 Million
Q3 2019 Nov 14, 2019	BUY	$10.16 - $13.28 $1.02 Million - $1.33 Million	100,200 Added 286.29%	135,199 $1.55 Million
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $2.12 Million - $3.32 Million	-200,016 Reduced 85.11%	34,999 $460,000
Q1 2019 May 14, 2019	SELL	$13.58 - $18.72 $11.3 Million - $15.6 Million	-831,832 Reduced 77.97%	235,015 $3.56 Million
Q4 2018 Feb 14, 2019	SELL	$14.78 - $19.68 $7.61 Million - $10.1 Million	-515,038 Reduced 32.56%	1,066,847 $18.3 Million
Q3 2018 Nov 14, 2018	BUY	$14.16 - $24.3 $18.4 Million - $31.6 Million	1,301,375 Added 463.93%	1,581,885 $23.3 Million
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $1.23 Million - $1.6 Million	56,486 Added 25.21%	280,510 $6.69 Million
Q1 2018 May 15, 2018	BUY	$18.15 - $29.21 $4.07 Million - $6.54 Million	224,024 New	224,024 $5.72 Million
Q4 2017 Feb 14, 2018	SELL	$9.3 - $19.14 $4.86 Million - $10 Million	-522,593 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$9.15 - $11.97 $4.78 Million - $6.26 Million	522,593	522,593 $5.48 Million

Others Institutions Holding COLL

# of Institutions

240

Shares Held

36.3M

Call Options Held

52.5K

Put Options Held

200

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.29B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Account